Media Room
Second Quarter 2025
Second quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation will be followed by a Q&A session.
14:30 – 15:30 CET (8:30am – 9:30am EDT)
Press releases
July 25, 2025
Press Release: Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma
July 22, 2025
Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline
July 18, 2025
Press Release: Sanofi completes acquisition of Blueprint Medicines
Contact Our Media Team
You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.
Publications
Sustainability Statement 2024 (ESG Report)
XBRL Viewer URD 2024
XBRL Viewer 20F 2024
Registration Document 2024 (in French)